PLYMOUTH TOWNSHIP, Mich. (Nov. 5, 2014)—Delphinus Medical Technologies Inc., announced that Shawn O’Brien has been named vice president of finance, expanding further the recent appointments to the executive leadership team.
O’Brien comes to Delphinus with extensive experience across a variety of corporate functions, most recently spear-heading all aspects of fiscal operations at CytoPherx. He was responsible for leading the project management team, including clinical trial guidance, and administering vendor relations. While at Kux Architectural Products, O’Brien was promoted to head of finance, advancing through successively responsible positions at the company. He began his professional career as controller at Advanced Material Process Corporation
“We are very pleased that Shawn has joined our team,” said Mark J. Forchette, president and chief executive officer of Delphinus. “We are entering an important growth phase, and his appointment is key as we develop a strong foundation to accelerate our strategies. Shawn’s contribution, based on his successful track record of knowledge and experience, will be critical as we move forward in our commitment to bring transformative advances in breast cancer screening with our SoftVue technology.”
O’Brien received his baccalaureate degree in accounting from University of Michigan in Flint, Michigan. In addition, he earned his MBA at the same institution.
